Allianz Slows Buyback Cadence at Record Highs as Overbought RSI and ECB Tightening Weigh
Published on 07/04/2026 at 18:07 | Redaktion boerse-global.de
Investors in Allianz have been rewarded with a fresh 52-week high of €421.40, yet the rally is looking increasingly fragile beneath the surface. The German insurer’s stock closed the week at €418.70, leaving it just 0.64% shy of that pinnacle. But the buying spree that propelled the shares 13.28% higher over the past month has begun to show cracks — most notably in the company’s own approach to its €2.5 billion buyback programme.
Launched in February, the repurchase plan was initially seen as a powerful tailwind. Allianz spent €300 million on its own equity in the first few months. Yet the pace has slowed markedly as the share price climbed. In the first week of June, the insurer snapped up more than 448,000 shares; by the final week of the same month, that figure had dropped to roughly 270,000. Capital discipline at elevated levels is a clear sign that management sees diminishing value at current prices.
That caution is echoed by the charts. The Relative Strength Index has surged to 77.6, deep into overbought territory and well above the conventional 70-point threshold. The stock has also stretched far from its moving averages: the spread to the 50-day line stands at 7.70%, while the gap to the 200-day average has widened to 11.66%. Such distances have historically tempted profit-taking.
Adding to the uncertainty is the European Central Bank. Eurozone inflation climbed to 3.2% in May, intensifying pressure on the central bank after it raised its key rate to 2.40% in June. Markets are now pricing in another increase at the July 23 meeting. For Allianz, higher rates are a double-edged sword: they bolster returns on the insurer’s vast investment portfolio, but they also fuel volatility in equity markets and weigh on a regional growth forecast that has been cut to just 0.8% for 2026.
Should investors sell immediately? Or is it worth buying Allianz?
Operationally, the picture remains solid. Allianz delivered a record first-quarter operating profit of €4.5 billion, and management has reaffirmed its full-year target of around €17.4 billion. The Solvency II ratio climbed to 221%, up two percentage points year-on-year, reflecting a robust capital position that supports both the buyback and potential acquisitions. The core property-and-casualty business continues to drive earnings, while return on equity stays elevated.
Analyst sentiment is divided but leans bullish. Berenberg recently lifted its price target sharply, from €504 to €684, arguing that the market underestimates the improving financial metrics among European composite insurers. It maintains a buy rating. Other voices, however, warn that the stock has already priced in much of the good news, leaving limited near-term upside.
A wild card is the potential acquisition of HSBC’s Singapore operations. Media reports flag Allianz as the frontrunner, though other bidders remain in the race. A successful deal would strategically strengthen the insurer’s footprint in Asia, injecting fresh growth narrative into the shares. Failure could see that fantasy deflate, even if the core business continues uninterrupted.
Allianz at a turning point? This analysis reveals what investors need to know now.
Should the rally stall, the moving averages provide a safety net. The 50-day line at €388.78 and the 200-day line at €374.98 represent key support zones. On a 12-month view, the stock has still gained 21.64%, and year-to-date the advance stands at 7.72%. A near-term pullback would not necessarily derail the longer-term uptrend.
The next major catalyst arrives on August 7, when Allianz publishes its first-half report. Those numbers will test the credibility of the €17.4 billion profit target. Until then, the interplay between a decelerating buyback, an overbought technical condition, and the ECB’s tightening bias will dictate the direction.
Ad
Allianz Stock: New Analysis - 4 July
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
